Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pivanex in Malignant Melanoma
NCT00087477Phase 2Terminated
- Sponsor
- Titan Pharmaceuticals, Inc.
- Start
- Jan 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pivaloyloxymethyl butyrate in Malignant Melanoma (MM), sponsored by Titan Pharmaceuticals, Inc.. Started Jan 2004; status: terminated.
02
Drugs
pivaloyloxymethyl butyrate
03
Conditions
Malignant Melanoma (MM)
Beyond the preview
Go deeper on NCT00087477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087477.